Quentin Youmans, MD, MSc, FACC, FHFSA
@QuentinYoumans
Followers
7K
Following
15K
Media
364
Statuses
5K
Yara’s dad | Advanced HF & Tx Cardiologist 🫀 @NMCardioVasc | Director of Pathway Programs & Student Support | #HealthEquity | AE @JCardFail | Opinions my own.
Chicago, IL
Joined February 2010
Innovation, Access, and the Future of Cardiac Care ft. Dr. Quentin Youmans
mdnewsline.com
In this episode of our Key Opinion Leader series, we speak with Dr. Quentin Youmans, a heart failure and transplant cardiologist at Northwestern Medicine. Dr. Youmans is recognized for his work...
0
0
4
Out now in @SCAI #HFC member @QuentinYoumans and his colleagues explore how interventional heart failure can drive progress in HF health equity. Read the full review https://t.co/rJjmzbNbZV
0
2
4
📖#InterventionalCardiology & #HeartFailure partner to care for patients across the spectrum of #HF care. In this comprehensive review, co-authors discuss how interventions can be used to promote #equity in #HF. Read more💡 ➡️ https://t.co/2oMMjjUr6c
@QuentinYoumans
2
4
8
Spanning #Equity in remote monitoring to cardiogenic shock, check out our team’s comprehensive review at the intersection of #HF, #InterventionalCardiology, and #Equity out in @MyJSCAI. https://t.co/ryAuo1eQ30 Shoutout to ⭐️ first author, @McGawGME resident Dr. @CedMutebi4!
1
3
12
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure: A Report of the American College of Cardiology Given emerging evidence of the benefits of semaglutide and tirzepatide in individuals with HFpEF and obesity in concert with healthy behavioral
3
25
78
The 2025 Framer Awards are open. Compete in 10 categories for $100,000 in prizes. New to Framer? Start building today and join the designers creating the internet’s best websites.
1
1
9
Join Quentin Youmans, MD (@QuentinYoumans), in the podcast studio to learn more about the novel, preventive strategies and multidisciplinary, patient-centric care happening at Northwestern Medicine Bluhm Cardiovascular Institute to help treat heart failure. Dr. Youmans served as
0
3
9
Join us today at 1p EST for our last @JCFINT Office Hours of 2025! @JasonKatzMD & I will be chatting about our first 2 issues (2nd issue drops tomorrow!) and looking ahead to what’s in store for 2026 Register here: https://t.co/VXdC8c49W4
@HFSA @SarahChuzi @ElliottMillerMD
1
10
28
Breakthrough Insights into Hemodynamics in Heart Failure 🩺 The latest issue of JCF spotlights the evolving role of hemodynamic assessment in heart failure management. Guest edited by Drs. Susanna Mak, Daniel Burkhoff, and Mark Belkin, this Focus Issue explores the resurgence
0
13
27
Begin your journey - the story is yours to tell. Join Ashes of Creation today and explore a world that grows with you.
0
0
0
🚨Check this out! In this 🔥 article, the authors used the AHA's GWTG HF registry to show a significant undertesting & underdiagnosis of ATTR-CM among pts hospitalized for HF, with substantial hospital-level variation across US hospitals. 🔗 https://t.co/U7n8BGD341
0
8
18
Just over a week left to join the @IllinoisACC’s Food for the Heart Initiative fighting food insecurity in Illinois! Thank you in advance for your generosity and for recognizing #FoodIsMedicine. 🥗
0
0
2
Closing out day two of #AHA25, Quentin R. Youmans, MD, MSc (@QuentinYoumans), presents, “Digital Connections: Expanding Cardiovascular Care Through Innovation”, in joint session with @AHAScience and @ABCardio1, “Bridging the Gap: Leveraging Innovation to Address Unmet Needs in
0
2
9
PREVENT equation 🤝 cardiovascular kidney metabolic health Learn more about CKM and PREVENT at #AHA25 🎥 @HeartDocSadiya
0
4
32
Dr. @AndrewJSauer providing salient context around prior discussions including: 1) The impact of dapagliflozin on blood pressure in DAPA ACT HF-TIMI 68. These meds are #Safe to start early and often. 2) The SOTA-P-CARDIA trial and the role of dual SGLT2/1 inhibition.
1
2
10
Don’t miss Quentin R. Youmans, MD, MSc (@QuentinYoumans), at #AHA25 during his session, “Digital Connections: Expanding Cardiovascular Care Through Innovation.” @AHAScience #AHA25 #NMatAHA. See the full schedule here: https://t.co/E5cUVUGHhJ
0
1
4
Dr. Andrew Wang discussing a pre-specified analysis of the MAPLE-HCM trial showing superiority of aficamten over beta blocker therapy in HCM. #AHA25
0
0
1
Dr. Larry Allen providing additional context around these discussions at #AHA25. The pillars of #GDMTWorks are strong, but still patients deal with polypharmacy. Need to be thoughtful about how we consider where we place newer therapies. @HFpEF @AHAScience
0
0
4
Powerwall delivers backup you can count on. Stay powered even when storms hit.
0
0
3
Back to back excellent talks at #AHA25. First on a study of the association between GWTG-HF and #GDMTWorks use. Second a deep dive into DIGIT-HF. @HFpEF @AHAScience
0
0
4
And we’re off! First up with Dr. Paul Heidenreich discussing how we use RCT data to update guidelines. How do we respond to new data? How do we adjust recommendations based on potential class effect? #AHA25
0
0
9
Are you at #AHA25? ❤️ Come join the session From Madrid to Mardi Gras: Heart Failure Trials on Parade at 1:30p today! @HFpEF @KhazanieHeart @AndrewJSauer
0
4
9